Pricing

Log inSign up

ADC Therapeutics

198 people · 0 jobs
‌

ADC Therapeutics is a clinical-stage oncology biotechnology company leading the development and commercialization of next-generation antibody drug conjugates (ADCs) with highly potent and targeted pyrrolobenzodiazepine (PBD) dimer technology.

Industries

Biotechnology

Headquarters

Lausanne, Switzerland

Employees

201-500

Links

Org chart

Ameet Mallik
CEO
Collapse
Kimberly Pope
Chief People Officer
Peter Graham
Chief Legal Officer
Jose Carmona
Chief Financial Officer
Kristen Harrington-Smith
Chief Commercial Officer
Mohamed Zaki
Chief Medical Officer
JF
Jay Feingold
Chief Medical Officer And Senior Vice President
Jesse Stromeyer
Executive Director, Head Of Marketing
NM
Niall McConnell
Head, Business Information Systems
JJ
Jim Jogerst
Chief Business Officer
NM
Niall M.
Chief Information Officer

Board & advisors

Ron Squarer
Chairman
Peter Hug
Vice-Chairman & Lead Independent Director
Stephen Evans-Freke
Non-Executive Director
Viviane Monges
Non-Executive Director
Thomas Pfisterer
Non-Executive Director
Tyrell J. Rivers
Non-Executive Director
Victor Sandor
Non-Executive Director
Jean-Pierre Bizzari
Non-Executive Director
Bob Azelby
Non-Executive Director

Teams

+12

Leadership Team

16 people · 0 jobs

+6

Clinical Operations and Development

10 people · 0 jobs

AB
CS
+7

Finance and Accounting

11 people · 0 jobs

Offices

Similar companies

Lonza

69 followers

Editas Medicine

5 followers

Roche

356 followers

Arcus Biosciences

3 followers

Sanofi

287 followers

Gilead Sciences

161 followers

Regeneron

132 followers

Illumina

79 followers

Agilent Technologies

82 followers

Verily Life Sciences

45 followers

Alexion Pharmaceuticals

45 followers

Explore companies